Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents

BACKGROUND: The emergence and spread of SARS-CoV-2 throughout the world has created an enormous socioeconomic impact. Although there are several promising drug candidates in clinical trials, none is available clinically. Thus, the drug repurposing approach may help to overcome the current pandemic....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Infect Public Health
Prif Awduron: Ahmed, Mohammad Z., Zia, Qamar, Haque, Anzarul, Alqahtani, Ali S., Almarfadi, Omar M., Banawas, Saeed, Alqahtani, Mohammed S., Ameta, Keshav L., Haque, Shafiul
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7871101/
https://ncbi.nlm.nih.gov/pubmed/33866129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2021.01.016
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg